Walgreens Boots Alliance Inc

Walgreens Boots Alliance (NASDAQ:WBA) missed Wall Street’s earnings forecast for the third quarter of fiscal 2020, which ended on May 31.

On Wednesday, Costco (NASDAQ:COST) reported its net sales for June. For the five weeks ended on July 5, the company reported net sales of $16.18 billion.

Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.

Today, CNBC reported that Walmart (NYSE:WMT) has acquired prescription management technology from CareZone to boost its pharmacy space.

Walgreens Boots Alliance (NASDAQ:WBA) reported strong earnings for the second quarter of fiscal 2020. The second quarter ended on February 29.

Analysts expect Walgreen’s second-quarter sales to rise 2.1% YoY to $35.3 billion. The company is scheduled to release its earnings results on April 2.

Walgreens Boots Alliance stock is feeling pressure again. The stock fell about 6% on Wednesday, which reflects its weaker start to fiscal 2020.

Kroger’s performance in recent quarters compared to its peers has left its investors unimpressed. In 2019, Kroger stock rose 5.4%.

Today, Walgreens Boots Alliance reported lower-than-expected results for the first quarter of fiscal 2020. The adjusted EPS fell on a YoY basis.

To diversify its business outside the advertising market, Alphabet is building several startup businesses in its Other Bets segment.

Walgreens Boots Alliance (WBA) will announce its earnings for the first quarter of fiscal 2020 before the markets open on January 8.

Apple (AAPL) kept the throne with a gain of almost 85% this year. The company is the third biggest component of the Dow Jones Index.

In addition to boosting dividends, many consumer stocks saw stellar growth in 2019. Most of these companies outperformed the benchmark index YTD.

Consumer stocks like Macy’s (M), Kraft Heinz (KHC), Gap (GPS), Altria (MO), and Walgreens (WBA) are lagging the broader markets by a wide margin.

Today, Evercore ISI upgraded its rating on Kroger to “outperform” from “in line” and Citigroup increased its price target on the stock to $32 from $30.

Delivery companies are poised to benefit from higher online retail sales this holiday season, but FedEx’s split from Amazon could make things dicey for it.

Aurora Cannabis (ACB) stock isn’t in the best shape today. As reported by BNN Bloomberg, the company’s CEO, Terry Booth, is justifiably worried.

CVS Health stock is up about 13% in November. Strong financial performance is driving the stock higher, but low earnings growth could limit further upside.

FedEx (FDX) stock gained nearly 3% on November 22. The company expects record package volumes on Cyber Monday.

Walgreens Boots Alliance (WBA) stock rose 5.1% on Monday. Bloomberg reported that private equity firm KKR has formally offered to buy the company.

Despite some impressive signs of Kroger’s (K) success, Walmart stock (WMT) is the better pick for the grocery sector. Here’s why. 

CVS Health (CVS) again beat analysts’ revenue and EPS estimates when it released its Q3 earnings today. Its stock was up about 3% in premarket trading.

Reuters reports that Walgreens Boots Alliance (WBA) is exploring options to go private and has engaged Evercore Partners to put together a deal.

CVS Health (CVS) is slated to announce its third-quarter earnings results tomorrow. We believe the company sustained its sales momentum in the quarter.

Warren Buffett entered the cannabis sector and Boeing experienced another massive loss. Plus, unrest in Hong Kong could hit the market.

Walgreens Boots Alliance (WBA) struggled in fiscal 2019. Sales headwinds and pressure on margins from reimbursements dragged the stock down.

Walgreens is scheduled to report its fourth-quarter earnings before the markets open on October 28. We expected a limited downside in Walgreens stock.

US retail sales grew by 3.5% in the first half of 2019. The retail sector of the S&P 500 Index includes 29 stocks representing a broad variety of retailers.

Apple (AAPL) shares have gained close to 50% year-to-date. The stock is trading at $235.87, while it’s valued at $1.07 trillion.

The retail sales for 2018 were $4.3 trillion. From January to July 2019, the retail sales in this category rose 3.5% over the comparable period in 2018.

The Dow Jones Industrial Average Index or DJIA gained a marginal 0.06% today to close trading just below 27,000—despite a bleak picture in Europe’s economy.

Pressure on Walgreens (WBA) stock had started easing a bit. However, the revival was short lived, and WBA fell about 2% last week.

FedEx (FDX) has teamed up with Alphabet’s (GOOGL) Wing to make drone delivery a reality. Let’s take a closer look at how.

The Dow Jones Industrial Average Index has fallen 0.4% or by 115 points today. The index is trading lower after rising for eight consecutive trading sessions.

KHC and WBA stocks have cost investors dearly. Warren Buffett’s Berkshire Hathaway has suffered for being Kraft Heinz’s biggest shareholder.

The Dow Jones Industrial Average has risen 51.5 points today—up for the eighth consecutive trading session. The DJIA is up 1,100 points since September 3.

Deutsche Bank started coverage on Walgreens stock with a “sell” recommendation. The stock closed 4.3% lower on Thursday after the news.

Walgreens Boots Alliance (WBA) stock underperformed CVS Health (CVS) stock last month, with Walgreens falling 6% and CVS rising about 9%.

Walgreens stock is underperforming and is trading at a low valuation. Despite this low valuation, the stock’s recovery could take time.

Today, Kroger (KR) and Walgreens Boots Alliance (WBA) announced the expansion of their strategic partnership. Let’s look at the details.

Walgreens and CVS Health shares are trading at a low valuation multiple. The stocks have fallen 22.3% and 8.7%, respectively, in 2019.

As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.

In a regulatory filing on Tuesday, Walgreens Boots Alliance (WBA) announced that it will close 200 stores in the US to focus on store optimization.

CVS Health (CVS) is set to announce its second-quarter results on August 7. We expect CVS to sustain its momentum in the quarter, supporting its stock.

On Wednesday, Walgreens announced a 4% hike in its quarterly dividend. The new quarterly dividend will be payable on September 12.

Amazon’s (AMZN) efforts to crack the more than $600 billion prescription drug market in the US has suffered a blow, albeit a mild one. A federal judge in Rhode Island ruled on June 18 that a former executive at pharmacy chain CVS Health (CVS) couldn’t work for Amazon’s pharmacy business, PillPack.

Wall Street expects Walgreens Boots Alliance’s (WBA) earnings to continue to decline in coming quarters, reflecting higher reimbursement pressure.

Walgreens Boots Alliance (WBA) stock is down about 17% since the company announced weak second-quarter earnings on April 2.

CVS Health (CVS) impressed investors with its first-quarter sales and earnings.

CVS Health (CVS) stock jumped 5.4% on May 1 on stronger-than-expected first-quarter results.

CVS Health (CVS) stock is trading at 7.8x its 2019 estimated EPS of $6.79.

CVS Health (CVS) plans to announce its first-quarter results on Wednesday, May 1.

Among the 27 analysts covering CVS Health (CVS) stock, 18 analysts suggest a “buy,” and nine analysts recommend a “hold.”

On April 15, Oppenheimer downgraded CVS Health (CVS) stock to “perform” from “outperform.”

CVS and Walgreens stock fell 17.7% and 7.4%, respectively, in the first quarter, which reflected the weak earnings outlook.

Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.

Analysts maintain a positive outlook on CVS Health (CVS) stock.

CVS Health (CVS) is down 19.4% on a YTD basis as of April 3.

Most analysts maintain a “hold” rating on Walgreens Boot Alliance (WBA) stock.

Walgreens Boots Alliance (WBA) posted adjusted earnings of $1.64 per share, a 5.4% decrease on a YoY basis.

Walgreens Boots Alliance’s (WBA) second-quarter sales of $34.5 billion increased 4.6% on a YoY basis.

Walgreens Boots Alliance (WBA) stock dropped 12.8% on Tuesday, April 2.

Walgreens Boot Alliance disappointed with weaker-than-expected earnings results for the second quarter of fiscal 2019 on April 2.

Walgreens Boots Alliance (WBA) reported dismal results for the second quarter of fiscal 2019 on April 2.

Analysts lowered their target price on Walgreens Boot Alliance (WBA) stock. On March 27, Cowen lowered its target price to $66 from $75.

Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of eligible products on its marketplace, the company confirmed to CNBC.

Walgreens Boot Alliance (WBA) shares have taken a beating the past few days. Multiple analysts lowered their target price on the stock.

Part of Walgreen’s (WBA) ongoing digital transformation involves making shopping more convenient for its customers.

Walgreens Boots Alliance (WBA) and CVS Health (CVS) shares have taken a beating. Bottom-line challenges spooked investors.

Walgreens Boots Alliance stock (WBA) fell 6.4% on March 1 after Baird’s reduction in target price.

Satya Nadella took over as CEO at Microsoft five years ago. Microsoft stock has risen almost 182% since Nadella took the reins.

Microsoft (MSFT) and Walgreens (WBA) announced last month that they would cooperate on developing digital healthcare solutions.

Walgreens Boots Alliance’s (WBA) gross margin continued to contract in the first quarter of fiscal 2019 after contracting in fiscal 2018.

Walgreens Boots Alliance’s (WBA) sales rose 9.9% to $33.8 billion in the first quarter of fiscal 2019 (which ended on November 30, 2018).

As of January 18, Walgreens Boots Alliance (WBA) stock has risen 6.0% since the start of 2019.

Earlier this morning, American tech giant Microsoft (MSFT) announced its strategic partnership with pharmaceutical firm Walgreens Boots Alliance (WBA).

Walgreens Boots Alliance (WBA) posted better-than-expected first-quarter results on Thursday, December 20.

So far, 2018 has been a difficult year for the consumer staples industry—even tougher than last year.

CVS Health posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock.

CVS Health (CVS) reported stronger-than-expected third-quarter sales. The company reported net sales of $47.3 billion.

CVS reported better-than-expected third-quarter results on November 6. The company’s top and bottom line exceeded analysts’ estimates.

Walgreens stock has fallen 2.4% YTD (year-to-date). It fell ~10% after Amazon announced the acquisition of Pillpack in June.

Walgreens’s Retail Pharmacy USA division accounted for 76% of fourth-quarter sales and increased 14.4% YoY to $25.5 billion.

RBC Capital Markets raised the price target for Walgreens Boots Alliance (WBA) from $68 to $82 (or ~20%) on Monday, October 8.

Walgreens Boots Alliance (WBA) is a well-covered stock. The company is tracked by 27 analysts and has a rating of 2.7 on a scale of 1 (strong buy) to 5 (sell).

To survive in the highly competitive pharmacy and retail space, Walgreens Boots Alliance (WBA) is entering into new innovative partnerships.

Wall Street expects a 10.7% year-over-year jump in Walgreens Boots Alliance’s (WBA) EPS to $1.45 during the fourth quarter of fiscal 2018.

Rite Aid (RAD) reported a second-quarter adjusted net loss from continuing operations of $7.9 million or $0.01 loss per share.

Rite Aid (RAD) reported results for the second quarter—which ended on September 1—yesterday. The company’s top line from continuing operations improved 1.4 % YoY (year-over-year) to $5.42 billion.

Struggling with the company’s financial position, Rite Aid’s management has tried to sell the company’s assets since 2015.

CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors.

CVS was upgraded by Citigroup from “neutral” to “buy” on July 9.

Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.

After Walgreens announced its fiscal Q3 results, Amazon announced its plan to acquire PillPack, an online pharmacy company, and WBA stock crashed.

Walgreens’s Retail Pharmacy USA division, which accounted for 75% of third-quarter sales, recorded a 15% YoY increase in revenue.

Walgreens’s fiscal third-quarter top line increased 14% YoY to $34.3 billion. On a constant currency basis, sales rose 11.8% YoY.